Po-Jung Su

发表

Clinical Factors Associated With Adherence to the Premedication Protocol for Withdrawal of Mechanical Ventilation in Terminally Ill Patients: A 4-Year Experience at a Single Medical Center in Asia

Hung-Ming Wang, W. Chou, C. Hsieh, 2018, The American journal of hospice & palliative care.

Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service.

Hung-Ming Wang, Chien-Ying Liu, Keng-Hao Liu, 2014, Journal of pain and symptom management.

Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer

J. Chiang, C. Chiu, Ching-Tai Huang, 2013, International journal of cancer.

Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy

Hung-Ming Wang, Min-Hsien Wu, C. Tseng, 2016, Scientific Reports.

Characteristics of Patients With Hematologic Malignancies Who Received Palliative Care Consultation Services in a Medical Center

Hung-Ming Wang, W. Chou, Jen‐Shi Chen, 2013, The American journal of hospice & palliative care.

Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.

C. Tseng, C. Hsieh, Y. Chao, 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

CD4+ T Cells Expressing Latency-Associated Peptide and Foxp3 Are an Activated Subgroup of Regulatory T Cells Enriched in Patients with Colorectal Cancer

J. Chiang, Ching-Tai Huang, Chun-Yen Lin, 2014, PloS one.

Caregivers' death-preparedness states impact caregiving outcomes and patients' end-of-life care.

S. Tang, F. Wen, W. Chou, 2021, Journal of pain and symptom management.

Terminally Ill Cancer Patients' Concordance Between Preferred Life-Sustaining Treatment States in Their Last Six Months of Life and Received Life-Sustaining Treatment States in Their Last Month: An Observational Study.

S. Tang, F. Wen, W. Chou, 2018, Journal of pain and symptom management.

Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinoma.

C. Hsieh, Hsin-I Tsai, Chao-Wei Lee, 2017, Oncology letters.

Long‐term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy‐naïve patients with metastatic castration‐resistant prostate cancer

D. Tsan, S. Pang, Ying-Hsu Chang, 2022, International journal of cancer.

Purely laparoscopic feeding jejunostomy: a procedure which deserves more attention

C. Hsieh, Chien-Chih Chiu, C. Yeh, 2021, BMC Surgery.

Longitudinal changes and predictors of caregiving burden while providing end-of-life care for terminally ill cancer patients.

S. Tang, W. Chou, Jen‐Shi Chen, 2013, Journal of palliative medicine.

Associations of death‐preparedness states with bereavement outcomes for family caregivers of terminally ill cancer patients

S. Tang, F. Wen, W. Chou, 2021, Psycho-oncology.

Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice

Chun-Chieh Huang, M. Kuo, Shau-Hsuan Li, 2020, Frontiers in Oncology.

Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma.

Hung-Ming Wang, Hsin-Yi Yang, Jen‐Shi Chen, 2011, Chang Gung medical journal.

LAP+CD4+ T Cells Are Suppressors Accumulated in the Tumor Sites and Associated with the Progression of Colorectal Cancer

J. Chiang, C. Chiu, Ching-Tai Huang, 2012, Clinical Cancer Research.

Human Cancer Biology LAP þ CD 4 þ T Cells Are Suppressors Accumulated in the Tumor Sites and Associated with the Progression of Colorectal Cancer

J. Chiang, C. Chiu, Ching-Tai Huang, 2012 .

Trajectories of the multidimensional dying experience for terminally ill cancer patients.

S. Tang, W. Chou, C. Hsieh, 2014, Journal of pain and symptom management.

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

Hung-Ming Wang, Min-Hsien Wu, Y. Chao, 2021, Cancer medicine.

First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis

Yu-Li Su, Shi-Yu Huang, Ting-ting Liu, 2022, Journal of immunotherapy.

Gonadotropin‐releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin‐releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study

L. See, J. Pang, Miao-Sui Lin, 2021, The Prostate.

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis

S. Park, N. Tsuchiya, Jae-Lyun Lee, 2022, International Journal of Clinical Oncology.

Trajectory and predictors of quality of life during the dying process: roles of perceived sense of burden to others and posttraumatic growth

S. Tang, W. Chou, Jen‐Shi Chen, 2014, Supportive Care in Cancer.

Validation of a palliative prognostic index to predict life expectancy for terminally ill cancer patients in a hospice consultation setting in Taiwan.

Hung-Ming Wang, W. Chou, Jen‐Shi Chen, 2012, Asian Pacific journal of cancer prevention : APJCP.

Paclitaxel and Carboplatin Versus Cisplatin and 5-Fluorouracil in Concurrent Chemoradiotherapy in Patients With Esophageal Cancer

C. Tseng, W. Chou, Yu-Ching Lin, 2021, In Vivo.

Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.

C. Tournigand, T. Powles, S. Park, 2022, European urology.

Decisional-regret trajectories from end-of-life decision making through bereavement.

S. Tang, F. Wen, Jen‐Shi Chen, 2023, Journal of pain and symptom management.

Depressive-symptom trajectories from end-of-life caregiving through the first 2 bereavement years for family caregivers of advanced cancer patients.

F. Wen, W. Chou, Jen‐Shi Chen, 2021, Journal of pain and symptom management.

Modifiable factors of depressive-symptom trajectories from caregiving through bereavement

S. Tang, F. Wen, Wen-Chi Shen, 2022, BMC Palliative Care.

Impact of palliative care consultative service on disease awareness for patients with terminal cancer

Hung-Ming Wang, W. Chou, Jen‐Shi Chen, 2013, Supportive Care in Cancer.

A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan

Á. Benedict, C. Goh, V. Kapetanakis, 2023, Cancer Reports.

745P Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC)

C. Tournigand, T. Powles, P. Grivas, 2020 .

Factors associated with family surrogate decisional-regret trajectories.

S. Tang, F. Wen, Wen‐Cheng Chang, 2023, Journal of Pain and Symptom Management.

Associations Between Surrogates' Decisional Regret Trajectories and Bereavement Outcomes.

S. Tang, F. Wen, Wen‐Cheng Chang, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Factors associated with cancer patients' distinct death‐preparedness states

S. Tang, F. Wen, Jen‐Shi Chen, 2023, Psycho-oncology.

Associations of surrogates' death‐preparedness states with decisional conflict and heightened decisional regret over cancer patients' last 6 months of life

S. Tang, F. Wen, W. Chou, 2022, Psycho-oncology.